 | • レポートコード：QYR2104Z1291 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、クラミジア診断検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（核酸増幅検査（NAAT）、直接蛍光検査）、用途別市場規模（病院、商業/民間研究所、診療所、公衆衛生研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・クラミジア診断検査の市場動向 ・企業の競争状況、市場シェア ・クラミジア診断検査の種類別市場規模（核酸増幅検査（NAAT）、直接蛍光検査） ・クラミジア診断検査の用途別市場規模（病院、商業/民間研究所、診療所、公衆衛生研究所） ・クラミジア診断検査の北米市場規模2016-2027（アメリカ、カナダ） ・クラミジア診断検査のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・クラミジア診断検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・クラミジア診断検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・クラミジア診断検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、ADI/American Diagnostica、Agilent Technologies、Chrono-Log、Corgenix、Decode Genetics、Diadexus、Diagnocure、Diagnostica Stago/Trinity Biotech、Diamedix、International Technidyne/Nexus DX、Kreatech/Leica、Polymedco、Qiagen、Roche、SDIX、Sequenom、Siemens） ・結論 |
Chlamydia Diagnostic Testing is used to screen for, diagnose, and verify successful treatment of infections caused by the bacteria Chlamydia trachomatis.
Market Analysis and Insights: Global Chlamydia Diagnostic Testing Market
The global Chlamydia Diagnostic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Chlamydia Diagnostic Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Chlamydia Diagnostic Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Chlamydia Diagnostic Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Chlamydia Diagnostic Testing market.
Global Chlamydia Diagnostic Testing Scope and Market Size
Chlamydia Diagnostic Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chlamydia Diagnostic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Nucleic Acid Amplification Tests (NAATs)
Direct Fluorescent Tests
Segment by Application
Hospitals
Commercial/Private Labs
Physician Offices
Public Health Labs
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott
ADI/American Diagnostica
Agilent Technologies
Chrono-Log
Corgenix
Decode Genetics
Diadexus
Diagnocure
Diagnostica Stago/Trinity Biotech
Chrono-Log
Corgenix
Kreatech/Leica
Polymedco
Qiagen
Roche
SDIX
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chlamydia Diagnostic Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Nucleic Acid Amplification Tests (NAATs)
1.2.3 Direct Fluorescent Tests
1.3 Market by Application
1.3.1 Global Chlamydia Diagnostic Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Commercial/Private Labs
1.3.4 Physician Offices
1.3.5 Public Health Labs
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Chlamydia Diagnostic Testing Market Perspective (2016-2027)
2.2 Chlamydia Diagnostic Testing Growth Trends by Regions
2.2.1 Chlamydia Diagnostic Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Chlamydia Diagnostic Testing Historic Market Share by Regions (2016-2021)
2.2.3 Chlamydia Diagnostic Testing Forecasted Market Size by Regions (2022-2027)
2.3 Chlamydia Diagnostic Testing Industry Dynamic
2.3.1 Chlamydia Diagnostic Testing Market Trends
2.3.2 Chlamydia Diagnostic Testing Market Drivers
2.3.3 Chlamydia Diagnostic Testing Market Challenges
2.3.4 Chlamydia Diagnostic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chlamydia Diagnostic Testing Players by Revenue
3.1.1 Global Top Chlamydia Diagnostic Testing Players by Revenue (2016-2021)
3.1.2 Global Chlamydia Diagnostic Testing Revenue Market Share by Players (2016-2021)
3.2 Global Chlamydia Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Chlamydia Diagnostic Testing Revenue
3.4 Global Chlamydia Diagnostic Testing Market Concentration Ratio
3.4.1 Global Chlamydia Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chlamydia Diagnostic Testing Revenue in 2020
3.5 Chlamydia Diagnostic Testing Key Players Head office and Area Served
3.6 Key Players Chlamydia Diagnostic Testing Product Solution and Service
3.7 Date of Enter into Chlamydia Diagnostic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chlamydia Diagnostic Testing Breakdown Data by Type
4.1 Global Chlamydia Diagnostic Testing Historic Market Size by Type (2016-2021)
4.2 Global Chlamydia Diagnostic Testing Forecasted Market Size by Type (2022-2027)
5 Chlamydia Diagnostic Testing Breakdown Data by Application
5.1 Global Chlamydia Diagnostic Testing Historic Market Size by Application (2016-2021)
5.2 Global Chlamydia Diagnostic Testing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Chlamydia Diagnostic Testing Market Size (2016-2027)
6.2 North America Chlamydia Diagnostic Testing Market Size by Type
6.2.1 North America Chlamydia Diagnostic Testing Market Size by Type (2016-2021)
6.2.2 North America Chlamydia Diagnostic Testing Market Size by Type (2022-2027)
6.2.3 North America Chlamydia Diagnostic Testing Market Size by Type (2016-2027)
6.3 North America Chlamydia Diagnostic Testing Market Size by Application
6.3.1 North America Chlamydia Diagnostic Testing Market Size by Application (2016-2021)
6.3.2 North America Chlamydia Diagnostic Testing Market Size by Application (2022-2027)
6.3.3 North America Chlamydia Diagnostic Testing Market Size by Application (2016-2027)
6.4 North America Chlamydia Diagnostic Testing Market Size by Country
6.4.1 North America Chlamydia Diagnostic Testing Market Size by Country (2016-2021)
6.4.2 North America Chlamydia Diagnostic Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Chlamydia Diagnostic Testing Market Size (2016-2027)
7.2 Europe Chlamydia Diagnostic Testing Market Size by Type
7.2.1 Europe Chlamydia Diagnostic Testing Market Size by Type (2016-2021)
7.2.2 Europe Chlamydia Diagnostic Testing Market Size by Type (2022-2027)
7.2.3 Europe Chlamydia Diagnostic Testing Market Size by Type (2016-2027)
7.3 Europe Chlamydia Diagnostic Testing Market Size by Application
7.3.1 Europe Chlamydia Diagnostic Testing Market Size by Application (2016-2021)
7.3.2 Europe Chlamydia Diagnostic Testing Market Size by Application (2022-2027)
7.3.3 Europe Chlamydia Diagnostic Testing Market Size by Application (2016-2027)
7.4 Europe Chlamydia Diagnostic Testing Market Size by Country
7.4.1 Europe Chlamydia Diagnostic Testing Market Size by Country (2016-2021)
7.4.2 Europe Chlamydia Diagnostic Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Chlamydia Diagnostic Testing Market Size (2016-2027)
8.2 Asia-Pacific Chlamydia Diagnostic Testing Market Size by Type
8.2.1 Asia-Pacific Chlamydia Diagnostic Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Chlamydia Diagnostic Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Chlamydia Diagnostic Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Chlamydia Diagnostic Testing Market Size by Application
8.3.1 Asia-Pacific Chlamydia Diagnostic Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Chlamydia Diagnostic Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Chlamydia Diagnostic Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Chlamydia Diagnostic Testing Market Size by Region
8.4.1 Asia-Pacific Chlamydia Diagnostic Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Chlamydia Diagnostic Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Chlamydia Diagnostic Testing Market Size (2016-2027)
9.2 Latin America Chlamydia Diagnostic Testing Market Size by Type
9.2.1 Latin America Chlamydia Diagnostic Testing Market Size by Type (2016-2021)
9.2.2 Latin America Chlamydia Diagnostic Testing Market Size by Type (2022-2027)
9.2.3 Latin America Chlamydia Diagnostic Testing Market Size by Type (2016-2027)
9.3 Latin America Chlamydia Diagnostic Testing Market Size by Application
9.3.1 Latin America Chlamydia Diagnostic Testing Market Size by Application (2016-2021)
9.3.2 Latin America Chlamydia Diagnostic Testing Market Size by Application (2022-2027)
9.3.3 Latin America Chlamydia Diagnostic Testing Market Size by Application (2016-2027)
9.4 Latin America Chlamydia Diagnostic Testing Market Size by Country
9.4.1 Latin America Chlamydia Diagnostic Testing Market Size by Country (2016-2021)
9.4.2 Latin America Chlamydia Diagnostic Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chlamydia Diagnostic Testing Market Size (2016-2027)
10.2 Middle East & Africa Chlamydia Diagnostic Testing Market Size by Type
10.2.1 Middle East & Africa Chlamydia Diagnostic Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Chlamydia Diagnostic Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Chlamydia Diagnostic Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Chlamydia Diagnostic Testing Market Size by Application
10.3.1 Middle East & Africa Chlamydia Diagnostic Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Chlamydia Diagnostic Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Chlamydia Diagnostic Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Chlamydia Diagnostic Testing Market Size by Country
10.4.1 Middle East & Africa Chlamydia Diagnostic Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Chlamydia Diagnostic Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Chlamydia Diagnostic Testing Introduction
11.1.4 Abbott Revenue in Chlamydia Diagnostic Testing Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 ADI/American Diagnostica
11.2.1 ADI/American Diagnostica Company Details
11.2.2 ADI/American Diagnostica Business Overview
11.2.3 ADI/American Diagnostica Chlamydia Diagnostic Testing Introduction
11.2.4 ADI/American Diagnostica Revenue in Chlamydia Diagnostic Testing Business (2016-2021)
11.2.5 ADI/American Diagnostica Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Chlamydia Diagnostic Testing Introduction
11.3.4 Agilent Technologies Revenue in Chlamydia Diagnostic Testing Business (2016-2021)
11.3.5 Agilent Technologies Recent Development
11.4 Chrono-Log
11.4.1 Chrono-Log Company Details
11.4.2 Chrono-Log Business Overview
11.4.3 Chrono-Log Chlamydia Diagnostic Testing Introduction
11.4.4 Chrono-Log Revenue in Chlamydia Diagnostic Testing Business (2016-2021)
11.4.5 Chrono-Log Recent Development
11.5 Corgenix
11.5.1 Corgenix Company Details
11.5.2 Corgenix Business Overview
11.5.3 Corgenix Chlamydia Diagnostic Testing Introduction
11.5.4 Corgenix Revenue in Chlamydia Diagnostic Testing Business (2016-2021)
11.5.5 Corgenix Recent Development
11.6 Decode Genetics
11.6.1 Decode Genetics Company Details
11.6.2 Decode Genetics Business Overview
11.6.3 Decode Genetics Chlamydia Diagnostic Testing Introduction
11.6.4 Decode Genetics Revenue in Chlamydia Diagnostic Testing Business (2016-2021)
11.6.5 Decode Genetics Recent Development
11.7 Diadexus
11.7.1 Diadexus Company Details
11.7.2 Diadexus Business Overview
11.7.3 Diadexus Chlamydia Diagnostic Testing Introduction
11.7.4 Diadexus Revenue in Chlamydia Diagnostic Testing Business (2016-2021)
11.7.5 Diadexus Recent Development
11.8 Diagnocure
11.8.1 Diagnocure Company Details
11.8.2 Diagnocure Business Overview
11.8.3 Diagnocure Chlamydia Diagnostic Testing Introduction
11.8.4 Diagnocure Revenue in Chlamydia Diagnostic Testing Business (2016-2021)
11.8.5 Diagnocure Recent Development
11.9 Diagnostica Stago/Trinity Biotech
11.9.1 Diagnostica Stago/Trinity Biotech Company Details
11.9.2 Diagnostica Stago/Trinity Biotech Business Overview
11.9.3 Diagnostica Stago/Trinity Biotech Chlamydia Diagnostic Testing Introduction
11.9.4 Diagnostica Stago/Trinity Biotech Revenue in Chlamydia Diagnostic Testing Business (2016-2021)
11.9.5 Diagnostica Stago/Trinity Biotech Recent Development
11.10 Diamedix
11.10.1 Diamedix Company Details
11.10.2 Diamedix Business Overview
11.10.3 Diamedix Chlamydia Diagnostic Testing Introduction
11.10.4 Diamedix Revenue in Chlamydia Diagnostic Testing Business (2016-2021)
11.10.5 Diamedix Recent Development
11.11 International Technidyne/Nexus DX
11.11.1 International Technidyne/Nexus DX Company Details
11.11.2 International Technidyne/Nexus DX Business Overview
11.11.3 International Technidyne/Nexus DX Chlamydia Diagnostic Testing Introduction
11.11.4 International Technidyne/Nexus DX Revenue in Chlamydia Diagnostic Testing Business (2016-2021)
11.11.5 International Technidyne/Nexus DX Recent Development
11.12 Kreatech/Leica
11.12.1 Kreatech/Leica Company Details
11.12.2 Kreatech/Leica Business Overview
11.12.3 Kreatech/Leica Chlamydia Diagnostic Testing Introduction
11.12.4 Kreatech/Leica Revenue in Chlamydia Diagnostic Testing Business (2016-2021)
11.12.5 Kreatech/Leica Recent Development
11.13 Polymedco
11.13.1 Polymedco Company Details
11.13.2 Polymedco Business Overview
11.13.3 Polymedco Chlamydia Diagnostic Testing Introduction
11.13.4 Polymedco Revenue in Chlamydia Diagnostic Testing Business (2016-2021)
11.13.5 Polymedco Recent Development
11.14 Qiagen
11.14.1 Qiagen Company Details
11.14.2 Qiagen Business Overview
11.14.3 Qiagen Chlamydia Diagnostic Testing Introduction
11.14.4 Qiagen Revenue in Chlamydia Diagnostic Testing Business (2016-2021)
11.14.5 Qiagen Recent Development
11.15 Roche
11.15.1 Roche Company Details
11.15.2 Roche Business Overview
11.15.3 Roche Chlamydia Diagnostic Testing Introduction
11.15.4 Roche Revenue in Chlamydia Diagnostic Testing Business (2016-2021)
11.15.5 Roche Recent Development
11.16 SDIX
11.16.1 SDIX Company Details
11.16.2 SDIX Business Overview
11.16.3 SDIX Chlamydia Diagnostic Testing Introduction
11.16.4 SDIX Revenue in Chlamydia Diagnostic Testing Business (2016-2021)
11.16.5 SDIX Recent Development
11.17 Sequenom
11.17.1 Sequenom Company Details
11.17.2 Sequenom Business Overview
11.17.3 Sequenom Chlamydia Diagnostic Testing Introduction
11.17.4 Sequenom Revenue in Chlamydia Diagnostic Testing Business (2016-2021)
11.17.5 Sequenom Recent Development
11.18 Siemens
11.18.1 Siemens Company Details
11.18.2 Siemens Business Overview
11.18.3 Siemens Chlamydia Diagnostic Testing Introduction
11.18.4 Siemens Revenue in Chlamydia Diagnostic Testing Business (2016-2021)
11.18.5 Siemens Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Chlamydia Diagnostic Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Nucleic Acid Amplification Tests (NAATs)
Table 3. Key Players of Direct Fluorescent Tests
Table 4. Global Chlamydia Diagnostic Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Chlamydia Diagnostic Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Chlamydia Diagnostic Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Chlamydia Diagnostic Testing Market Share by Regions (2016-2021)
Table 8. Global Chlamydia Diagnostic Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Chlamydia Diagnostic Testing Market Share by Regions (2022-2027)
Table 10. Chlamydia Diagnostic Testing Market Trends
Table 11. Chlamydia Diagnostic Testing Market Drivers
Table 12. Chlamydia Diagnostic Testing Market Challenges
Table 13. Chlamydia Diagnostic Testing Market Restraints
Table 14. Global Chlamydia Diagnostic Testing Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Chlamydia Diagnostic Testing Market Share by Players (2016-2021)
Table 16. Global Top Chlamydia Diagnostic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chlamydia Diagnostic Testing as of 2020)
Table 17. Ranking of Global Top Chlamydia Diagnostic Testing Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Chlamydia Diagnostic Testing Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Chlamydia Diagnostic Testing Product Solution and Service
Table 21. Date of Enter into Chlamydia Diagnostic Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Chlamydia Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Chlamydia Diagnostic Testing Revenue Market Share by Type (2016-2021)
Table 25. Global Chlamydia Diagnostic Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Chlamydia Diagnostic Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Chlamydia Diagnostic Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Chlamydia Diagnostic Testing Revenue Market Share by Application (2016-2021)
Table 29. Global Chlamydia Diagnostic Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Chlamydia Diagnostic Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Chlamydia Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Chlamydia Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Chlamydia Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Chlamydia Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Chlamydia Diagnostic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Chlamydia Diagnostic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Chlamydia Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Chlamydia Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Chlamydia Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Chlamydia Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Chlamydia Diagnostic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Chlamydia Diagnostic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Chlamydia Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Chlamydia Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Chlamydia Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Chlamydia Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Chlamydia Diagnostic Testing Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Chlamydia Diagnostic Testing Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Chlamydia Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Chlamydia Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Chlamydia Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Chlamydia Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Chlamydia Diagnostic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Chlamydia Diagnostic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Chlamydia Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Chlamydia Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Chlamydia Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Chlamydia Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Chlamydia Diagnostic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Chlamydia Diagnostic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abbott Company Details
Table 62. Abbott Business Overview
Table 63. Abbott Chlamydia Diagnostic Testing Product
Table 64. Abbott Revenue in Chlamydia Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 65. Abbott Recent Development
Table 66. ADI/American Diagnostica Company Details
Table 67. ADI/American Diagnostica Business Overview
Table 68. ADI/American Diagnostica Chlamydia Diagnostic Testing Product
Table 69. ADI/American Diagnostica Revenue in Chlamydia Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 70. ADI/American Diagnostica Recent Development
Table 71. Agilent Technologies Company Details
Table 72. Agilent Technologies Business Overview
Table 73. Agilent Technologies Chlamydia Diagnostic Testing Product
Table 74. Agilent Technologies Revenue in Chlamydia Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 75. Agilent Technologies Recent Development
Table 76. Chrono-Log Company Details
Table 77. Chrono-Log Business Overview
Table 78. Chrono-Log Chlamydia Diagnostic Testing Product
Table 79. Chrono-Log Revenue in Chlamydia Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 80. Chrono-Log Recent Development
Table 81. Corgenix Company Details
Table 82. Corgenix Business Overview
Table 83. Corgenix Chlamydia Diagnostic Testing Product
Table 84. Corgenix Revenue in Chlamydia Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 85. Corgenix Recent Development
Table 86. Decode Genetics Company Details
Table 87. Decode Genetics Business Overview
Table 88. Decode Genetics Chlamydia Diagnostic Testing Product
Table 89. Decode Genetics Revenue in Chlamydia Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 90. Decode Genetics Recent Development
Table 91. Diadexus Company Details
Table 92. Diadexus Business Overview
Table 93. Diadexus Chlamydia Diagnostic Testing Product
Table 94. Diadexus Revenue in Chlamydia Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 95. Diadexus Recent Development
Table 96. Diagnocure Company Details
Table 97. Diagnocure Business Overview
Table 98. Diagnocure Revenue in Chlamydia Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 99. Diagnocure Recent Development
Table 100. Diagnostica Stago/Trinity Biotech Company Details
Table 101. Diagnostica Stago/Trinity Biotech Business Overview
Table 102. Diagnostica Stago/Trinity Biotech Chlamydia Diagnostic Testing Product
Table 103. Diagnostica Stago/Trinity Biotech Revenue in Chlamydia Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 104. Diagnostica Stago/Trinity Biotech Recent Development
Table 105. Diamedix Company Details
Table 106. Diamedix Business Overview
Table 107. Diamedix Chlamydia Diagnostic Testing Product
Table 108. Diamedix Revenue in Chlamydia Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 109. Diamedix Recent Development
Table 110. International Technidyne/Nexus DX Company Details
Table 111. International Technidyne/Nexus DX Business Overview
Table 112. International Technidyne/Nexus DX Chlamydia Diagnostic Testing Product
Table 113. International Technidyne/Nexus DX Revenue in Chlamydia Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 114. International Technidyne/Nexus DX Recent Development
Table 115. Kreatech/Leica Company Details
Table 116. Kreatech/Leica Business Overview
Table 117. Kreatech/Leica Chlamydia Diagnostic Testing Product
Table 118. Kreatech/Leica Revenue in Chlamydia Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 119. Kreatech/Leica Recent Development
Table 120. Polymedco Company Details
Table 121. Polymedco Business Overview
Table 122. Polymedco Chlamydia Diagnostic Testing Product
Table 123. Polymedco Revenue in Chlamydia Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 124. Polymedco Recent Development
Table 125. Qiagen Company Details
Table 126. Qiagen Business Overview
Table 127. Qiagen Chlamydia Diagnostic Testing Product
Table 128. Qiagen Revenue in Chlamydia Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 129. Qiagen Recent Development
Table 130. Roche Company Details
Table 131. Roche Business Overview
Table 132. Roche Chlamydia Diagnostic Testing Product
Table 133. Roche Revenue in Chlamydia Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 134. Roche Recent Development
Table 135. SDIX Company Details
Table 136. SDIX Business Overview
Table 137. SDIX Chlamydia Diagnostic Testing Product
Table 138. SDIX Revenue in Chlamydia Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 139. SDIX Recent Development
Table 140. Sequenom Company Details
Table 141. Sequenom Business Overview
Table 142. Sequenom Chlamydia Diagnostic Testing Product
Table 143. Sequenom Revenue in Chlamydia Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 144. Sequenom Recent Development
Table 145. Siemens Company Details
Table 146. Siemens Business Overview
Table 147. Siemens Chlamydia Diagnostic Testing Product
Table 148. Siemens Revenue in Chlamydia Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 149. Siemens Recent Development
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chlamydia Diagnostic Testing Market Share by Type: 2020 VS 2027
Figure 2. Nucleic Acid Amplification Tests (NAATs) Features
Figure 3. Direct Fluorescent Tests Features
Figure 4. Global Chlamydia Diagnostic Testing Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Commercial/Private Labs Case Studies
Figure 7. Physician Offices Case Studies
Figure 8. Public Health Labs Case Studies
Figure 9. Chlamydia Diagnostic Testing Report Years Considered
Figure 10. Global Chlamydia Diagnostic Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Chlamydia Diagnostic Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Chlamydia Diagnostic Testing Market Share by Regions: 2020 VS 2027
Figure 13. Global Chlamydia Diagnostic Testing Market Share by Regions (2022-2027)
Figure 14. Global Chlamydia Diagnostic Testing Market Share by Players in 2020
Figure 15. Global Top Chlamydia Diagnostic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chlamydia Diagnostic Testing as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Chlamydia Diagnostic Testing Revenue in 2020
Figure 17. Global Chlamydia Diagnostic Testing Revenue Market Share by Type (2016-2021)
Figure 18. Global Chlamydia Diagnostic Testing Revenue Market Share by Type (2022-2027)
Figure 19. North America Chlamydia Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Chlamydia Diagnostic Testing Market Share by Type (2016-2027)
Figure 21. North America Chlamydia Diagnostic Testing Market Share by Application (2016-2027)
Figure 22. North America Chlamydia Diagnostic Testing Market Share by Country (2016-2027)
Figure 23. United States Chlamydia Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Chlamydia Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Chlamydia Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Chlamydia Diagnostic Testing Market Share by Type (2016-2027)
Figure 27. Europe Chlamydia Diagnostic Testing Market Share by Application (2016-2027)
Figure 28. Europe Chlamydia Diagnostic Testing Market Share by Country (2016-2027)
Figure 29. Germany Chlamydia Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Chlamydia Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Chlamydia Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Chlamydia Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Chlamydia Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Chlamydia Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Chlamydia Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Chlamydia Diagnostic Testing Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Chlamydia Diagnostic Testing Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Chlamydia Diagnostic Testing Market Share by Region (2016-2027)
Figure 39. China Chlamydia Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Chlamydia Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Chlamydia Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Chlamydia Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Chlamydia Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Chlamydia Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Chlamydia Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Chlamydia Diagnostic Testing Market Share by Type (2016-2027)
Figure 47. Latin America Chlamydia Diagnostic Testing Market Share by Application (2016-2027)
Figure 48. Latin America Chlamydia Diagnostic Testing Market Share by Country (2016-2027)
Figure 49. Mexico Chlamydia Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Chlamydia Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Chlamydia Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Chlamydia Diagnostic Testing Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Chlamydia Diagnostic Testing Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Chlamydia Diagnostic Testing Market Share by Country (2016-2027)
Figure 55. Turkey Chlamydia Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Chlamydia Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Chlamydia Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Abbott Revenue Growth Rate in Chlamydia Diagnostic Testing Business (2016-2021)
Figure 59. ADI/American Diagnostica Revenue Growth Rate in Chlamydia Diagnostic Testing Business (2016-2021)
Figure 60. Agilent Technologies Revenue Growth Rate in Chlamydia Diagnostic Testing Business (2016-2021)
Figure 61. Chrono-Log Revenue Growth Rate in Chlamydia Diagnostic Testing Business (2016-2021)
Figure 62. Corgenix Revenue Growth Rate in Chlamydia Diagnostic Testing Business (2016-2021)
Figure 63. Decode Genetics Revenue Growth Rate in Chlamydia Diagnostic Testing Business (2016-2021)
Figure 64. Diadexus Revenue Growth Rate in Chlamydia Diagnostic Testing Business (2016-2021)
Figure 65. Diagnocure Revenue Growth Rate in Chlamydia Diagnostic Testing Business (2016-2021)
Figure 66. Diagnostica Stago/Trinity Biotech Revenue Growth Rate in Chlamydia Diagnostic Testing Business (2016-2021)
Figure 67. Diamedix Revenue Growth Rate in Chlamydia Diagnostic Testing Business (2016-2021)
Figure 68. International Technidyne/Nexus DX Revenue Growth Rate in Chlamydia Diagnostic Testing Business (2016-2021)
Figure 69. Kreatech/Leica Revenue Growth Rate in Chlamydia Diagnostic Testing Business (2016-2021)
Figure 70. Polymedco Revenue Growth Rate in Chlamydia Diagnostic Testing Business (2016-2021)
Figure 71. Qiagen Revenue Growth Rate in Chlamydia Diagnostic Testing Business (2016-2021)
Figure 72. Roche Revenue Growth Rate in Chlamydia Diagnostic Testing Business (2016-2021)
Figure 73. SDIX Revenue Growth Rate in Chlamydia Diagnostic Testing Business (2016-2021)
Figure 74. Sequenom Revenue Growth Rate in Chlamydia Diagnostic Testing Business (2016-2021)
Figure 75. Siemens Revenue Growth Rate in Chlamydia Diagnostic Testing Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
世界のクラミジア感染症検査市場規模・現状・予測（2021年-2027年） Chlamydia Infection Test is used to screen for, diagnose, and verify successful treatment of infections caused by the bacteria Chlamydia trachomatis. Market Analysis and Insights: Global Chlamydia Infection Test Market The global Chlamydia Infection Test market size is projected to reach US$ XX mill…- 世界のクラミジア感染症診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Chlamydia Infection Diagnostics Market The global Chlamydia Infection Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data i…
- 世界のクラミジア感染症診断・治療市場規模・現状・予測（2021年-2027年） The chlamydia infection diagnostics and therapeutics market unveils high potential owing to the rapidly rising patient pool and vast untapped opportunities. Market Analysis and Insights: Global Chlamydia Infection Diagnostics and Therapeutics Market The global Chlamydia Infection Diagnostics and The…
- 世界の核酸増幅検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Nucleic Acid Amplification Testing Market The global Nucleic Acid Amplification Testing market size is projected to reach US$ 177.3 million by 2026, from US$ 131.5 million in 2019, at a CAGR of 4.3% during 2021-2026. With industry-standard accuracy in analysis an…
- 世界の診察室診断検査市場規模・現状・予測（2021年-2027年） Physician office diagnostic testing is similar to the point-of-care diagnostic testing which are carried out in physician’s office, hospital, home and others. The physician office diagnostic testing market is expected to grow at a rapid growth rate over the forecast period owing to the increasing se…